SMSPHARMA Stock Overview
Manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
SMS Pharmaceuticals Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹334.50 |
52 Week High | ₹363.75 |
52 Week Low | ₹111.85 |
Beta | 1.26 |
11 Month Change | 13.16% |
3 Month Change | 67.00% |
1 Year Change | 162.35% |
33 Year Change | 105.59% |
5 Year Change | 570.34% |
Change since IPO | 831.11% |
Recent News & Updates
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40
Aug 22Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%
Aug 20SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Aug 08Recent updates
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40
Aug 22Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%
Aug 20SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Aug 08What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You
Jul 04Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly
Jun 21SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden
Dec 09Should You Take Comfort From Insider Transactions At SMS Pharmaceuticals Limited (NSE:SMSPHARMA)?
Nov 18The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 110% And Shareholders Are Boasting About It
Oct 28Shareholder Returns
SMSPHARMA | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -1.3% | 2.2% | 0.6% |
1Y | 162.4% | 59.1% | 41.9% |
Return vs Industry: SMSPHARMA exceeded the Indian Pharmaceuticals industry which returned 59.1% over the past year.
Return vs Market: SMSPHARMA exceeded the Indian Market which returned 41.9% over the past year.
Price Volatility
SMSPHARMA volatility | |
---|---|
SMSPHARMA Average Weekly Movement | 8.8% |
Pharmaceuticals Industry Average Movement | 6.1% |
Market Average Movement | 6.4% |
10% most volatile stocks in IN Market | 9.6% |
10% least volatile stocks in IN Market | 3.9% |
Stable Share Price: SMSPHARMA's share price has been volatile over the past 3 months.
Volatility Over Time: SMSPHARMA's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 1,095 | Ramesh Potluri | www.smspharma.com |
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, anti-epileptic, anti-psychotic, anti-inflammatory, anti-fungal, anti-viral, anti-coagulant, and anti-retroviral products. It is also involved in the contract research activities.
SMS Pharmaceuticals Limited Fundamentals Summary
SMSPHARMA fundamental statistics | |
---|---|
Market cap | ₹28.32b |
Earnings (TTM) | ₹569.64m |
Revenue (TTM) | ₹7.38b |
49.7x
P/E Ratio3.8x
P/S RatioIs SMSPHARMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SMSPHARMA income statement (TTM) | |
---|---|
Revenue | ₹7.38b |
Cost of Revenue | ₹5.16b |
Gross Profit | ₹2.22b |
Other Expenses | ₹1.65b |
Earnings | ₹569.64m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 6.73 |
Gross Margin | 30.12% |
Net Profit Margin | 7.71% |
Debt/Equity Ratio | 52.4% |
How did SMSPHARMA perform over the long term?
See historical performance and comparisonDividends
0.1%
Current Dividend Yield7%
Payout RatioDoes SMSPHARMA pay a reliable dividends?
See SMSPHARMA dividend history and benchmarksSMS Pharmaceuticals dividend dates | |
---|---|
Ex Dividend Date | Sep 23 2024 |
Dividend Pay Date | Oct 30 2024 |
Days until Ex dividend | 16 days |
Days until Dividend pay date | 53 days |
Does SMSPHARMA pay a reliable dividends?
See SMSPHARMA dividend history and benchmarks